The coronavirus outbreak is a rapidly developing situation. Please visit the NHS website for the most up-to-date information for people in the UK.
There is very rapidly evolving data concerning Covid-19 and we will try and keep our members appraised of the lasted evidence based, specialist society supported, information. One of the most useful things that we can do is to ensure that patients are very well educated as to “sick day rules”, and which medications to “pause” at times of inter-current illness (which is covered in out SGLT2 document).
The National Diabetes Inpatient COVID Response Team
- View letter from The National Diabetes Inpatient COVID Response Team highlighting the need to maintain patient safety whilst accelerating patient flow through the system including preventing avoidable admissions and readmissions.
- Maintaining acute diabetes services in response to COVID-19
- Speciality template for acute diabetes services
- SBar for COVID-19 and Diabetes
- COncise adVice on Inpatient Diabetes (COVID:Diabetes) - Front Door Guidance (Version 3.1, Updated November 2020)
- COncise adVice on Inpatient Diabetes - Guidelines for managing DKA using subcutaneous insulin
- COncise adVice on Inpatient Diabetes - Guidance for managing inpatient hyperglycaemia
- COncise adVice on Inpatient Diabetes - Dexamethasone therapy in covid-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes. (Updated November 2020)
- COncise adVice on Inpatient Diabetes - Safe and supported discharge to reduce readmissions and improve patient flow
- COncise adVice on Inpatient Diabetes - Hyperglycaemia/diabetes Guidance For People With COVID-19 Infections Managed In A Virtual Ward
- COncise adVice on Inpatient Diabetes - Post COVID-19 diebetes discharge pathway - risk stratification and follow up guidance for people being discharged from secondary care after COVID-19 infection
Coronavirus Information for Healthcare Professionals
- Public Health England - COVID-19: infection prevention and control
- NHS England: coronavirus for health professionals
- NICE published first rapid COVID-19 Guidelines
- Royal College of Obstetricians and Gynaecologists (RCOG): coronavirus advice for pregnant women
- Society for Endocrinology: adrenal crisis information and COVID-19 resources for managing endocrine conditions
- Guidance for inpatient diabetes care webinar from National Inpatient Diabetes COVID-19 Response group
- European Journal of Endocrinology COVID-19 Collection
- London Diabetes Clinical Network Guidance documents that support the delivery of diabetes care in London during the pandemic
- ABCD Meeting Secretary, Dr Dipesh Patel, speaks on Covid-19: how vulnerable are people with diabetes? in this short podcast
- A Covid-19 Response Action – Diabetes Management in Care Homes
- Covid-19 update: Guidance and Resources for primary care and patients
- London COVID-19 dexamethasone and hyperglycaemia: diabetes de-escalation guidance
- Dexamethasone and Oxygen Therapy in Care Home Residents with Diabetes – A Management Guide and Algorithm for Treatment
Specialist Organisations
- Renal Association
- Advice to people with Diabetes
- Advice regarding ACEi/ARB medication from ESC
- Resuscitation Council UK
- Primary Care Diabetes Society
- EASD Covid19 and diabetes e-learning modules
Guidance from the UK's public health bodies
- Public Health England
- Health Protection Scotland
- Public Health Wales
- HSC Public Health Agency (Northern Ireland)
Specialty guides for patient management, issued by the NHS on 16/3/2020
- General and internal medicine and coronavirus
- Diabetes and coronavirus updated 19/03/2020
- ITU and coronavirus
- Neuro trauma and coronavirus
- Orthopaedic trauma and coronavirus
- Surgery and coronavirus
Gov.uk Drug Safety Update published 18/03/2020
SGLT2 inhibitors:monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness
Royal College of Physicians regarding CPD
Announcement from the Royal College of Physicians on CPD Requirements